BDBM293986 4-(4-(5-((4-((2S)-1-(1H- Tetrazol-5-yl)pent-3-yn-2- yl)phenoxy)methyl)-2- methylbenzo[b]thiophen-3-yl)- 3-methylphenoxy)tetrahydro- 2H-thiopyran 1,1-dioxide::US10106553, Compound 18

SMILES CC#C[C@@H](Cc1nnn[nH]1)c1ccc(OCc2ccc3sc(C)c(-c4ccc(OC5CCS(=O)(=O)CC5)cc4C)c3c2)cc1

InChI Key

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 293986   

TargetFree fatty acid receptor 1(Homo sapiens (Human))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM293986(4-(4-(5-((4-((2S)-1-(1H- Tetrazol-5-yl)pent-3-yn-2...)
Affinity DataEC50:  80nMT: 2°CAssay Description:Compounds were tested in a calcium flux assay using transfected HEK293 cells stably expressing either human GPR40 or rat GPR40. Human GPR40 expressin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent